These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1998682)

  • 1. Mechanism of inactivation and identification of sites of modification of ornithine aminotransferase by 4-aminohex-5-ynoate.
    De Biase D; Simmaco M; Barra D; Bossa F; Hewlins M; John RA
    Biochemistry; 1991 Feb; 30(8):2239-46. PubMed ID: 1998682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stoichiometry and stability of the adduct formed between human 4-aminobutyrate aminotransferase and 4-aminohex-5-enoate: sequence of a labelled peptide.
    De Biase D; Bolton JB; Barra D; Bossa F; John RA
    Biochimie; 1989 Apr; 71(4):491-5. PubMed ID: 2503053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-activated irreversible inhibitors of L-ornithine:2-oxoacid aminotransferase. Demonstration of mechanistic features of the inhibition of ornithine aminotransferase by 4-aminohex-5-ynoic acid and gabaculine and correlation with in vivo activity.
    Jung MJ; Seiler N
    J Biol Chem; 1978 Oct; 253(20):7431-9. PubMed ID: 701263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-induced inactivation of transminases by acetylenic and vinyl analogues of 4-aminobutyrate.
    John RA; Jones ED; Fowler LJ
    Biochem J; 1979 Feb; 177(2):721-8. PubMed ID: 435262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kinetic model for the action of the enzyme activated irreversible inhibitor 4-amino-5-hexynoic acid in vivo.
    Carney IT; Miller SA; Basford JM; John RA
    Biochem Pharmacol; 1984 Dec; 33(23):3765-9. PubMed ID: 6508832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry of the inactivation of 4-aminobutyrate aminotransferase by the antiepileptic drug vigabatrin.
    De Biase D; Barra D; Bossa F; Pucci P; John RA
    J Biol Chem; 1991 Oct; 266(30):20056-61. PubMed ID: 1939068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the properties of ornithine aminotransferase after inactivation by the 'suicide' inhibitor aminohexynoate and use of the compound as a probe of intracellullar protein turnover.
    Jones ED; Basford JM; John RA
    Biochem J; 1983 Jan; 209(1):243-9. PubMed ID: 6847611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain.
    Daune G; Seiler N
    Neurochem Res; 1988 Jan; 13(1):69-75. PubMed ID: 2897088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptic cleavage as a probe of conformational differences between active and inactive forms of ornithine aminotransferase.
    Simmaco M; Carr L; Bossa F; Barra D; Basford JM; John RA
    J Biol Chem; 1989 May; 264(13):7473-6. PubMed ID: 2708372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of inhibition of ornithine aminotransferase by L-canaline.
    Kito K; Sanada Y; Katunuma N
    J Biochem; 1978 Jan; 83(1):201-6. PubMed ID: 624704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions of glutamate semialdehyde aminotransferase (glutamate-1-semialdehyde 2,1 aminomutase) with vinyl and acetylenic substrate analogues analysed by rapid scanning spectrophotometry.
    Tyacke RJ; Contestabile R; Grimm B; Harwood JL; John RA
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):307-13. PubMed ID: 7619072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine.
    Storici P; Capitani G; Müller R; Schirmer T; Jansonius JN
    J Mol Biol; 1999 Jan; 285(1):297-309. PubMed ID: 9878407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase.
    Bolkenius FN; Knödgen B; Seiler N
    Biochem J; 1990 Jun; 268(2):409-14. PubMed ID: 2363680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereochemistry of the inactivation of 4-aminobutyrate: 2-oxoglutarate aminotransferase and L-glutamate 1-carboxylase by 4-aminohex-5-ynoic acid enantiomers.
    Danzin C; Claverie N; Jung MJ
    Biochem Pharmacol; 1984 Jun; 33(11):1741-6. PubMed ID: 6375677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopencillanic acid: mechanism.
    Cohen SA; Pratt RF
    Biochemistry; 1980 Aug; 19(17):3996-4003. PubMed ID: 6773559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase.
    Daune G; Gerhart F; Seiler N
    Biochem J; 1988 Jul; 253(2):481-8. PubMed ID: 3178724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The primary structure of ornithine aminotransferase. Identification of active-site sequence and site of post-translational proteolysis.
    Simmaco M; John RA; Barra D; Bossa F
    FEBS Lett; 1986 Apr; 199(1):39-42. PubMed ID: 3754226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a lysine residue at a nucleotide binding site in the firefly luciferase with p-fluorosulfonyl[14C]benzoyl-5'-adenosine.
    Lee Y; Esch FS; DeLuca MA
    Biochemistry; 1981 Mar; 20(5):1253-6. PubMed ID: 6784750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid sequence of Salmonella typhimurium branched-chain amino acid aminotransferase.
    Feild MJ; Nguyen DC; Armstrong FB
    Biochemistry; 1989 Jun; 28(12):5306-10. PubMed ID: 2669973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and properties of ornithine-oxo-acid aminotransferase of rat kidney. Comparison with the liver enzyme.
    Kalita CC; Kerman JD; Strecker HJ
    Biochim Biophys Acta; 1976 May; 429(3):780-97. PubMed ID: 1268231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.